AdaptHealth Corp. (AHCO)

AdaptHealth Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	79.57	77.13	46.27	149.63	99.96	76.88
Cash & Cash Equivalents	79.57	77.13	46.27	149.63	99.96	76.88
Cash Growth	-21.53%	66.69%	-69.08%	49.68%	30.03%	205.24%
Receivables	429.56	388.91	359.15	359.9	171.07	78.62
Inventory	108.59	113.64	127.75	123.1	58.78	13.24
Other Current Assets	38.27	69.34	52.14	37.44	33.44	12.68
Total Current Assets	655.98	649.02	585.31	670.06	363.25	181.42
Property, Plant & Equipment	643.55	637.53	622.01	546.34	110.47	63.56
Goodwill and Intangibles	2,843	2,855	3,708	3,715	1,115	266.79
Other Long-Term Assets	361.14	366.98	304.2	319.29	224.88	34.77
Total Long-Term Assets	3,848	3,860	4,634	4,580	1,450	365.12
Total Assets	4,504	4,509	5,220	5,250	1,813	546.54
Accounts Payable	340.23	391.99	337.5	358.38	254.21	102.73
Deferred Revenue	34.04	38.57	31.64	31.37	11.04	9.56
Current Debt	80.78	91.76	67.21	66.86	30.43	21.47
Other Current Liabilities	37.64	14.68	19.86	43.19	126.37	20.3
Total Current Liabilities	492.69	537	456.21	499.81	422.05	154.05
Long-Term Debt	2,264	2,203	2,262	2,304	776.57	395.11
Other Long-Term Liabilities	275.64	302.09	344	380.25	334.01	63.16
Total Long-Term Liabilities	2,540	2,505	2,606	2,684	1,111	458.27
Total Liabilities	3,033	3,042	3,062	3,184	1,533	612.32
Total Debt	2,345	2,295	2,329	2,371	807	416.58
Debt Growth	0.05%	-1.47%	-1.76%	193.76%	93.72%	168.47%
Retained Earnings	-654.73	-652.6	26.3	-43.02	-199.2	-40.26
Comprehensive Income	5.21	4.36	8.69	-2.35	-4.41	1.43
Shareholders' Equity	1,462	1,458	2,151	2,062	354.89	-38.82
Net Cash / Debt	-2,265.54	-2,217.52	-2,282.55	-2,220.97	-707.03	-339.71
Net Cash Per Share	-17.05	-16.50	-16.42	-16.69	-13.47	-15.06
Working Capital	163.29	112.02	129.09	170.25	-58.8	27.36
Book Value Per Share	11.00	10.87	16.03	16.32	6.76	-1.72

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).